Region Zealand Report issue

Government Phase 2 Phase 4

Organization Overview

First Clinical Trial
2009
NCT01636674
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Epilepsihospitalet Filadelfia | Region Zealand

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenoma (Phase 2)

Alzheimer Disease (Phase 4)

Colonic Neoplasms (Phase 2)

Dementia (Phase 4)

Infarction (Phase 4)

Lewy Body Disease (Phase 4)

Myocardial Infarction (Phase 4)

Non-ST Elevated Myocardial Infarction (Phase 4)

Parkinson Disease (Phase 4)

ST Elevation Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 10